Cargando…

Recuperating Biopharmaceutical Aspects of Amphotericin B and Paromomycin Using a Chitosan Functionalized Nanocarrier via Oral Route for Enhanced Anti-leishmanial Activity

The design and development of new pharmaceutical formulations for the existing anti-leishmanial is a new strategic alternate to improve efficacy and safety rather than new drug discovery. Herein hybrid solid lipid nanoparticles (SLN) have been engineered to direct the oral delivery of two anti-leish...

Descripción completa

Detalles Bibliográficos
Autores principales:	Parvez, Shabi, Yadagiri, Ganesh, Karole, Archana, Singh, Om Prakash, Verma, Anurag, Sundar, Shyam, Mudavath, Shyam Lal
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2020
Materias:	Cellular and Infection Microbiology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7593694/ https://www.ncbi.nlm.nih.gov/pubmed/33178626 http://dx.doi.org/10.3389/fcimb.2020.570573

Ejemplares similares

Modified solid lipid nanoparticles encapsulated with Amphotericin B and Paromomycin: an effective oral combination against experimental murine visceral leishmaniasis
por: Parvez, Shabi, et al.
Publicado: (2020)

Evaluation of Safety and Antileishmanial Efficacy of Amine Functionalized Carbon-Based Composite Nanoparticle Appended With Amphotericin B: An in vitro and Preclinical Study
por: Gedda, Mallikarjuna Rao, et al.
Publicado: (2020)

Sensible graphene oxide differentiates macrophages and Leishmania: a bio-nano interplay in attenuating intracellular parasite
por: Singh, Aakriti, et al.
Publicado: (2020)

Characterization and evaluation of amine-modified graphene amphotericin B for the treatment of visceral leishmaniasis: in vivo and in vitro studies
por: Mudavath, Shyam Lal, et al.
Publicado: (2014)

Immunotherapy and immunochemotherapy in combating visceral leishmaniasis
por: Yadagiri, Ganesh, et al.
Publicado: (2023)

Efficacy and Safety of Paromomycin in Treatment of Post-Kala-Azar Dermal Leishmaniasis
por: Sundar, Shyam, et al.
Publicado: (2014)

Liposomal Amphotericin B and Leishmaniasis: Dose and Response
por: Sundar, Shyam, et al.
Publicado: (2010)

Phase 4 Pharmacovigilance Trial of Paromomycin Injection for the Treatment of Visceral Leishmaniasis in India
por: Sinha, Prabhat K., et al.
Publicado: (2011)

Transcriptome profiling identifies genes/pathways associated with experimental resistance to paromomycin in Leishmania donovani
por: Verma, Aditya, et al.
Publicado: (2017)

Recuperation
por: Vittorio Frigo
Publicado: (1999)

Recuperation
Publicado: (1892)

Potential and Applications of Nanocarriers for Efficient Delivery of Biopharmaceuticals
por: Zeb, Alam, et al.
Publicado: (2020)

Transcriptional blood signatures for active and amphotericin B treated visceral leishmaniasis in India
por: Fakiola, Michaela, et al.
Publicado: (2019)

Recupere su mercado
por: Sheth, Jagdish
Publicado: (1992)

Recuperating Effect of Sleep
Publicado: (1898)

Leishmanial Abscess
por: Arora, Sandeep, et al.
Publicado: (2017)

Experimental Induction of Paromomycin Resistance in Antimony-Resistant Strains of L. donovani: Outcome Dependent on In Vitro Selection Protocol
por: Hendrickx, Sarah, et al.
Publicado: (2012)

Paromomycin Affects Translation and Vesicle-Mediated Trafficking as Revealed by Proteomics of Paromomycin –Susceptible –Resistant Leishmania donovani
por: Chawla, Bhavna, et al.
Publicado: (2011)

A Critical Recuperation of Watsuji’s Rinrigaku
por: Zanghellini, Aleardo, et al.
Publicado: (2020)

Sustained and Universal Fertility Recuperation in Kazakhstan
por: Kan, Maxim
Publicado: (2023)

Development of mannose-anchored thiolated amphotericin B nanocarriers for treatment of visceral leishmaniasis
por: Shahnaz, Gul, et al.
Publicado: (2017)

Récupération des rejets thermiques de LEP
por: Barbalat, O
Publicado: (1979)

Récupération des rejets thermiques de LEP
por: Barbalat, O
Publicado: (1979)

Endoreversible Modeling of a Hydraulic Recuperation System
por: Masser, Robin, et al.
Publicado: (2020)

Topical paromomycin for New World cutaneous leishmaniasis
por: Sosa, Néstor, et al.
Publicado: (2019)

Paromomycin is superior to metronidazole in Dientamoeba fragilis treatment
por: Burgaña, Ander, et al.
Publicado: (2019)

Efficacy and Safety of Amphotericin B Emulsion versus Liposomal Formulation in Indian Patients with Visceral Leishmaniasis: A Randomized, Open-Label Study
por: Sundar, Shyam, et al.
Publicado: (2014)

Geographical Variability in Paromomycin Pharmacokinetics Does Not Explain Efficacy Differences between Eastern African and Indian Visceral Leishmaniasis Patients
por: Verrest, Luka, et al.
Publicado: (2021)

rf cavity for the Novosibirsk race-track microtron-recuperator
por: Gavrilov, N G, et al.
Publicado: (1994)

An energy recuperation scheme for a two-beam accelerator
por: Henke, H
Publicado: (1988)

Recuperation of Sick and Wounded to Front from Psychological Viewpoint
por: Laignel-Lavastine
Publicado: (1918)

Immunotherapy and Targeted Therapies in Treatment of Visceral Leishmaniasis: Current Status and Future Prospects
por: Singh, Om Prakash, et al.
Publicado: (2014)

Developments in Diagnosis of Visceral Leishmaniasis in the Elimination Era
por: Singh, Om Prakash, et al.
Publicado: (2015)

Interest in paromomycin for the treatment of visceral leishmaniasis (kala-azar)
por: Wiwanitkit, Viroj
Publicado: (2012)

Effect of topical Nanoliposomes of Paromomycin on Rats Liver and Kidney
por: Kalantari, Heibatullah, et al.
Publicado: (2014)

Cryptosporidiosis in a renal transplant patient treated with paromomycin
por: Khalil-ur-Rahman,, et al.
Publicado: (2007)

A Case of Filariasis of the Eye
por: Srivastava, Shyam Sundar Lal
Publicado: (1945)

A Short Pulse Two-Beam Accelerator with Energy Recuperation
por: Henke, H
Publicado: (2004)

Recuperation/recirculation system at P5 (external environment report)
por: Ordan, Julien Marius
Publicado: (2019)

Promoter Trapping in Microalgae Using the Antibiotic Paromomycin as Selective Agent
por: Vila, Marta, et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_js4qr06s7ehunq3cgr0q34hc3s